While an improved picture of the diversity and metabolic capabilities of environmentally significant microorganisms now exists, direct links between phylogenetic diversity and activity of heterotrophic marine bacterioplankton remain elusive. We propose to address this gap with a series of laboratory and field experiments designed with the ultimate goal of measuring in situ growth rates of specific members of the bacterioplankton by direct measurement of the expression of genes involved in fundamental cellular processes (e.g. cellular division, DNA replication, etc.). An advantage of this approach is that instantaneous population parameters are measured directly without labile DOC amendment or incubation. Also, the activity of specific bacterial populations, rather than entire communities, will be monitored and thus provide an improved understanding of the significance of community structure to ecosystem function. Efforts will focus on the Roseobacter lineage of marine bacteria. Members of this clade are ubiquitous and often abundant in marine plankton, have been linked to specific and significant biogeochemical roles and are a main focus of recent whole genome sequencing efforts.
Dataset | Latest Version Date | Current State |
---|---|---|
CTD - Bottles from R/V Hugh R. Sharp HRS070714AB in the Chesapeake Bay from July 2007 (Assessing Roseobacter activities project) | 2014-01-16 | Final no updates expected |
CTD - Profiles from R/V Hugh R. Sharp HRS070714AB in the Chesapeake Bay from July 2007 (Assessing Roseobacter activities project) | 2011-06-14 | Final no updates expected |
CTD - Stations from R/V Hugh R. Sharp HRS070714AB in the Chesapeake Bay from July 2007 (Assessing Roseobacter activities project) | 2011-06-14 | Final no updates expected |
Cruise Track from R/V Hugh R. Sharp HRS070714AB in the Chesapeake Bay from July 2007 (Assessing Roseobacter activities project) | 2011-06-13 | Final no updates expected |
Lead Principal Investigator: Alison Buchan
University of Tennessee Knoxville (UTK)
Co-Principal Investigator: Marcelino T Sukuki
Chesapeake Bay Laboratories (CBL)